A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
Clinical trial NCT04464707 · COMPLETED
Trial details
- NCT number
- NCT04464707
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-24
- Primary completion
- 2024-11-29
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.